Dow Up0.07% Nasdaq Up0.61%

Response Genetics, Inc (RGDX)

-NasdaqCM
0.49 Up 0.00(0.41%) Nov 26, 3:59PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 19,801   18,737   22,643  
Cost of Revenue10,456  10,416  11,734  
Gross Profit 9,345   8,321   10,909  
Operating Expenses
Research Development1,607  2,129  1,322  
Selling General and Administrative15,684  13,849  15,269  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (7,946) (7,657) (5,682)
Income from Continuing Operations
Total Other Income/Expenses Net17  (14)0  
Earnings Before Interest And Taxes(7,929)(7,671)(5,682)
Interest Expense92  86  21  
Income Before Tax(8,021)(7,757)(5,702)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(8,021)(7,757)(5,702)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (8,021) (7,757) (5,702)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (8,021) (7,757) (5,702)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.